FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to a transepicutal pharmaceutical composition that contains rotigotin and used in effective treatment of the restless legs syndrome (RLS), especially in form of transdermal therapeutic system based on acrylate or silicon having surface 2.5-20 cm2 and containing rotigotin in the concentration 1.125-9.0 mg/cm2 as an active component against restless less syndrome. The composition improves state of patients suffering from restless legs syndrome as compared with treatment with placebo by 2 units or more according assessment scale of International investigation group of restless legs syndrome (IRLSSG) after administration of the composition for at least 8 days.
EFFECT: valuable property and enhanced effectiveness of formulation.
20 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DEVICE FOR TRANSDERMAL INTRODUCTION OF ROTIGOTINE IN ORGANISM IN FORM OF BASE | 2003 |
|
RU2340339C2 |
| PERCUTANEOUS THERAPEUTIC SYSTEM FOR TREATMENT OF PARKINSON'S DISEASE INDUCING HIGH ROTIGOTIN PLASMA LEVEL | 2002 |
|
RU2272625C2 |
| IMPROVED TRANSCUTANEOUS THERAPY SYSTEM FOR TREATING PARKINSON DISEASE CASES | 2002 |
|
RU2273477C2 |
| THERMOFUSIBLE TTS FOR APPLYING ROTIGOTIN | 2003 |
|
RU2304434C2 |
| IONTOPHORETIC ROTIGOTINE DELIVERY IN TREATMENT FOR PARKINSON'S DISEASE | 2003 |
|
RU2339372C2 |
| IONOPHORETIC DELIVERY OF ROTIGOTINE FOR TREATMENT OF PARKINSON DISEASE | 2008 |
|
RU2478383C2 |
| TRANSDERMAL GRANISETRON | 2004 |
|
RU2355387C2 |
| 5,6,7,8-TETRAHYDRO-6-[N,N-BIS[(2-THIENYL)ETHYL]]AMINO-1-NAPHTHOL AND PREPARATION METHOD AND USE THEREOF | 2012 |
|
RU2609807C2 |
| TREATMENT AND PREVENTION OF RESTLESS LEG SYNDROME WITH USING GABA ANALOGUE PRODRUGS | 2004 |
|
RU2458049C2 |
| TREATMENT OR PREVENTION OF RESTLESS LEGS SYNDROME WITH USING PROMEDICINES OF GABA ANALOGUES | 2004 |
|
RU2377234C2 |
